Transgene inks pact with Portugal’s Atral Cipan
Biotechnology firm Transgene Biotek has entered into a licencing pact with Portugal-based Atral Cipan for its immunosuppressive drug Tacrolimus. As a result, Atral Cipan will move the product through regulatory filings with the US Food and Drug Administration and European Medicines Agency for the manufacturing and marketing of Tacrolimus.
Swiss tool maker Starrag to set up Bangalore plant
Swiss-based machine tool maker Starrag Group will open its first manufacturing plant in Bangalore with an investment of R70 crore. This was one of the first investment proposals promised at the Global Investors Meet, 2010 organised by the Karnataka government. The factory in Devanahalli will employ around 300 people.
Be the first to comment.